Medicare Enrolled
Dr. Farhad Niroomand, M.D.
Procedural Dermatology Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Niroomand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Niroomand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Niroomand
Dr. Farhad Niroomand is a procedural dermatology physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Niroomand performed 2,360 Medicare services across 1,449 unique beneficiaries.
Between the years covered by Open Payments, Dr. Niroomand received a total of $8,566 from 34 pharmaceutical and/or device companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Niroomand is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 2,360 Medicare services
$8,566 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,360
Medicare services
Bottom 32% in TX for procedural dermatology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,449
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~118 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
520 | $64 | $122 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
467 | $5 | $13 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
275 | $38 | $121 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $38 | $75 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
165 | $77 | $186 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
110 | $1 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $97 | $178 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
55 | $75 | $178 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
42 | $119 | $284 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
37 | $294 | $494 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
35 | $196 | $378 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
28 | $46 | $125 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
26 | $37 | $91 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
25 | $114 | $235 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
21 | $113 | $231 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
19 | $99 | $164 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
19 | $107 | $421 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
18 | $86 | $192 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
17 | $356 | $883 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
17 | $122 | $258 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $11 | $26 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
16 | $77 | $184 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
15 | $95 | $189 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
15 | $60 | $130 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
13 | $98 | $348 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
13 | $310 | $585 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
12 | $71 | $205 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
11 | $57 | $145 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $131 | $315 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,566
Total received (2018-2024)
Avg $1,224/year across 7 years
Top 38% in TX for procedural dermatology physician
34
Companies
471
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,246 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$321 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,991
2023
$1,818
2022
$1,066
2021
$863
2020
$888
2019
$1,004
2018
$936
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,161
Lilly USA, LLC
$669
ABBVIE INC.
$659
Amgen Inc.
$585
Dermavant Sciences, Inc.
$536
Regeneron Healthcare Solutions, Inc.
$482
E.R. Squibb & Sons, L.L.C.
$427
PFIZER INC.
$416
Arcutis Biotherapeutics, Inc.
$416
AbbVie, Inc.
$414
UCB, Inc.
$353
GENZYME CORPORATION
$288
AbbVie Inc.
$272
LEO Pharma Inc.
$230
Galderma Laboratories, L.P.
$179
Genentech USA, Inc.
$167
Sun Pharmaceutical Industries Inc.
$157
Incyte Corporation
$137
SUN PHARMACEUTICAL INDUSTRIES INC.
$136
DUSA Pharmaceuticals, Inc.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
DERMIRA, INC.
$96
Ortho Dermatologics, a division of Bausch Health US, LLC
$89
Biofrontera Inc.
$83
Allergan, Inc.
$83
Allergan Inc.
$51
MAYNE PHARMA INC.
$46
Celgene Corporation
$42
Novartis Pharmaceuticals Corporation
$39
Sebela Pharmaceuticals Inc.
$29
Janssen Scientific Affairs, LLC
$22
Journey Medical Corporation
$21
SANOFI-AVENTIS U.S. LLC
$20
Mylan Pharmaceuticals Inc.
$16
Top 3 companies account for 29.1% of total payments
Associated products mentioned in payments ›
20% · ADBRY · AMELUZ · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · Otezla · PRAMOSONE · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $363 per 100 Medicare services performed
Geographic Context
Procedural dermatology physicians within 10 mi
16
Per 100K population
0.6
County median income
$74,149
Nearest hospital
TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Niroomand is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Niroomand experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Niroomand performed 520 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Niroomand receive payments from pharmaceutical companies?
Yes. Dr. Niroomand received a total of $8,566 from 34 companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Niroomand's costs compare to other procedural dermatology physicians in Dallas?
Dr. Niroomand's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Niroomand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Dallas
Browse procedural dermatology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in TX
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in TX
Which TX procedural dermatology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology